Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series

Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series

Abstract Background Immune checkpoint inhibition is part of standard systemic management for many advanced malignancies. Toxicities from this treatment approach are unpredictable, though usually reversible with management per established guidelines. Some patients suffer major morbidity and treatment...

Full description

Bibliographic Details
Main Authors: Puja Arora, Laura Talamo, Patrick Dillon, Ryan D. Gentzler, Trish Millard, Michael Salerno, Craig L. Slingluff, Elizabeth M. Gaughan
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cardio-Oncology
Subjects:
Combination immunotherapy
Immune related adverse events
Myocarditis
Myasthenia gravis
Myositis
Online Access:http://link.springer.com/article/10.1186/s40959-020-00076-6

Internet

http://link.springer.com/article/10.1186/s40959-020-00076-6

Similar Items